Our data show that oncogenic KRAS CRC cells are highly transcriptionally responsive to activation of the EGFR via TGFα stimulation, which is surprising as mtKRAS is thought to decouple downstream signalling from EGFR stimulation. The gene discussed is KRAS; the disease is colorectal carcinoma.